Medical Device Reprocessing Market Research Report - Global Forecast till 2027

Medical Device Reprocessing Market Segmentation by Product & Service: Reprocessed Medical Devices, Reprocessing Support and Services; Type of Medical Device: Catheters, Laparoscopy Instruments, Biopsy Instruments, Endoscopy Instruments, Cables, Columns, and Cutters; Application: General Surgery, Cardiology, Orthopedic, Gastroenterology, Urology and Regions - Forecast to 2027

ID: MRFR/HC/7324-HCR | February 2021 | Region: Global | 108 pages

Medical Device Reprocessing Market Synopsis


Medical Device Reprocessing Market is expected to cross USD 2,671.8 Million by 2025 at a CAGR of 16.4%. Medical device reprocessing is a method carried out on a medical device for its safe reuse, including disinfection, cleaning, sterilization, and other related procedures such as testing and restoring the functional and technical safety of the devices. The commercial medical device reprocessing of single-use medical devices offers safe and effective patient care solutions while lowering the cost of waste disposal and reducing medical waste.


Medical Device Reprocessing Market Influencer


The positive changes in the regulatory scenario are favoring medical device reprocessing in the number of countries such as France and Japan. For example, the outsourcing of medical device reprocessing was prohibited in France till 2016; however, on April 5, 2017, the European Union (EU) Regulations (Article 17) was released, which mandated the use of third-party reprocessing services by all French hospitals. These regulations are expected to be implemented in France by 2020. This will positively influence the growth of the market. 


Medical Device Reprocessing Market Drivers



  • Low cost of the reprocessed medical device. The reprocessed medical devices typically cost between 40-60% less than the original medical device. The adoption of the low-cost reprocessed device is a huge cost saving to the organization.


Commonly reprocessed medical devices



  • Rising needs to reduce the generation of medical waste. Most single-use medical devices which are not collected for reprocessing are generated as regulated medical waste. Healthcare organizations pay a premium of 6-10 times higher to dispose of regulated medical waste than solid waste. For instance, according to AMDR survey, healthcare organizations across the U.S., Canada, and Europe saved USD 471 million and diverted 15 million pounds of medical waste by using reprocessed devices in 2016. The reprocessing of medical devices helps to eliminate medical waste and thereby to drive the growth of the market.


Medical Device Reprocessing Market Restraints



  • Risks associated with the reprocessed medical device. The reprocessing of the medical device is a complex and technical process. It raises concerns about patient safety, environment, and ethics.


Medical Device Reprocessing Market Segmentation


By Product & Service



  • Reprocessed Medical Devices: The increasing use of reprocessed products in various surgeries such as cardiac surgery and low prices of reprocessed medical devices as compared to new devices is attributive to the growth of this segment size. In the United States, it is reported that more than 25% of hospitals reused at least one type of single-use devices (SUDs) in 2016.



  • Reprocessing Support and Services: The largest segment. The growth of this segment is attributed to the rising preference of customers for reprocessing services by third-party reprocessors with reduced expenses and decreased environmental impact.


By Type of Medical Device



  • Catheters: The largest segment and expected to grow at the highest CAGR during the forecast period. The growing applications of reprocessed cardiology, electrophysiology, and diagnostic catheters. Moreover, an average of five uses for each diagnostic catheter and three uses for each angioplasty catheter may save approximately USD 5000 and USD 100,000 respectively, per 100 procedures.



  • Laparoscopy Instruments: The demand for properly cleaned and sterilized laparoscopy instruments is increasing due to the rise in laparoscopic procedures.



  • Biopsy Instruments: The rise in the adoption of reprocessed biopsy instruments by hospitals and clinics for various biopsy procedures is driving the growth of this segment.



  • Endoscopy Instruments: The increased utilization of reprocessed endoscopy instruments in recent years is driving the growth of this segment.  In the US, approximately 4.0 million endoscopy procedures of the large intestine were performed in 2017.



  • Cables, Columns, and Cutters: The rising usage of cables, columns and cutters in hospitals and surgical centers is expected to be beneficial for the growth of the medical device reprocessing market.


By Application



  • General Surgery: The growth of this segment is attributable to the increasing adoption of reprocessed surgical instruments in hospitals and other healthcare facilities.



  • Cardiology: The largest segment. The American Society of Cardiac Arrhythmias has given a favorable opinion to reprocess electrophysiological devices. The Food and Drug Administration (FDA) classifies electrophysiological cardiac catheters in Class 2 surgical devices and allows its reprocessing in the US. This is favoring market growth.



  • Orthopedic: The growing geriatric population and the increasing number of orthopedic surgical procedures are responsible for orthopedic segment growth.



  • Gastroenterology: The increasing popularity of laparoscopic surgery and rising awareness regarding gastroenterological disorders is positively influencing the market growth.



  • Urology: The increasing prevalence of urological surgeries is increasing the demand for this segment.



  • Others


Medical Device Reprocessing Market By Region



  • Americas: The largest regional market. The presence of a favorable regulatory scenario for increasing the safety and efficacy of the reprocessed medical device is boosting the demand for the same. Moreover, the rising prevalence of chronic diseases, along with an increase in the number of surgical procedures, is majorly contributing to the growth of this region.



  • Europe: The cost-saving through medical device reprocessing and regulatory pressure to reduce the generation of medical waste is leading to a rise in the adoption of reprocessed medical devices.



  • Asia-Pacific: The fastest-growing regional market. The reuse of medical devices in most Asian countries is common, especially for injection needles.



  • Middle East & Africa: The smallest market due to limited healthcare infrastructure in this region.


Medical Device Reprocessing Market Key Players



  • Stryker Corporation (US)

  • Johnson & Johnson (US)

  • Medtronic PLC (Ireland)

  • Vanguard AG (Germany)

  • Medline Industries, Inc. (US)

  • AGITO MEDICAL A/S (Denmark)

  • EverX Pvt Ltd (Australia)

  • Block Imaging (US)

  • SureTek Medical (US)

  • ReNu Medical, Inc. (Arjo) (US)

  • SteriPro (Canada)



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 2,671.8 Million
  CAGR   16.4% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product & Service, Type of Medical Device and Application
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Stryker Corporation (US), Johnson & Johnson (US), Medtronic PLC (Ireland), Vanguard AG (Germany), Medline Industries, Inc. (US), AGITO MEDICAL A/S (Denmark), EverX Pvt Ltd (Australia), Block Imaging (US), SureTek Medical (US), ReNu Medical, Inc. (Arjo) (US)and SteriPro (Canada)
  Key Market Opportunities   The positive changes in the regulatory scenario are favoring medical device reprocessing in the number of countries such as France and Japan
  Key Market Drivers

  • Low cost of the reprocessed medical device
  • Commonly reprocessed medical devices




  • This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.